Total Payments
$2,204
2024 Payments
$1,058
Companies
17
Transactions
112
Medicare Patients
854
Medicare Billing
$83,307
Payment Breakdown by Category
Food & Beverage$1,946 (88.3%)
Education$258.94 (11.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,946 | 109 | 88.3% |
| Education | $258.94 | 3 | 11.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $332.82 | 6 | $0 (2024) |
| Incyte Corporation | $285.74 | 20 | $0 (2024) |
| Janssen Biotech, Inc. | $280.03 | 10 | $0 (2024) |
| ABBVIE INC. | $249.73 | 22 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $226.51 | 11 | $0 (2024) |
| Dermavant Sciences, Inc. | $213.46 | 15 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $109.87 | 2 | $0 (2021) |
| Amgen Inc. | $96.33 | 5 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $80.53 | 5 | $0 (2024) |
| LEO Pharma Inc. | $74.59 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,058 | 61 | E.R. Squibb & Sons, L.L.C. ($158.58) |
| 2023 | $592.26 | 35 | Incyte Corporation ($146.45) |
| 2022 | $271.74 | 9 | GENZYME CORPORATION ($118.40) |
| 2021 | $269.01 | 6 | GENZYME CORPORATION ($125.06) |
| 2020 | $13.92 | 1 | Lilly USA, LLC ($13.92) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.41 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.67 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $8.18 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.46 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $8.89 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.18 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.93 | General |
| Category: Dermatology | ||||||
| 10/02/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Immunology | ||||||
| 10/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: Immunology | ||||||
| 09/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.68 | General |
| Category: Dermatology | ||||||
| 08/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: Immunology | ||||||
| 08/27/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.81 | General |
| Category: Immunology | ||||||
| 08/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.04 | General |
| Category: Immunology | ||||||
| 08/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.90 | General |
| Category: Immunology | ||||||
| 08/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Immunology | ||||||
| 06/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Inflammation | ||||||
| 06/04/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.12 | General |
| Category: Dermatology | ||||||
| 05/30/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 854 | 1,398 | $340,017 | $83,307 |
Total Patients
854
Total Services
1,398
Medicare Billing
$83,307
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 171 | $58,573 | $16,882 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 168 | 197 | $48,631 | $13,740 | 28.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 78 | 82 | $29,100 | $7,995 | 27.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 82 | 98 | $30,968 | $7,955 | 25.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 41 | 52 | $35,860 | $7,402 | 20.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 26 | 27 | $26,001 | $7,321 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $29,477 | $7,177 | 24.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 123 | 150 | $38,051 | $6,392 | 16.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 41 | 41 | $14,074 | $3,808 | 27.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 92 | 507 | $17,732 | $3,009 | 17.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 15 | $11,550 | $1,626 | 14.1% |
About Dr. Joseph Aleshaki, DO
Dr. Joseph Aleshaki, DO is a MOHS-Micrographic Surgery healthcare provider based in Santee, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2018. The National Provider Identifier (NPI) number assigned to this provider is 1548766264.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Aleshaki, DO has received a total of $2,204 in payments from pharmaceutical and medical device companies, with $1,058 received in 2024. These payments were reported across 112 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,946).
As a Medicare-enrolled provider, Aleshaki has provided services to 854 Medicare beneficiaries, totaling 1,398 services with total Medicare billing of $83,307. Data is available for 1 year (2023–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Procedural Dermatology, Dermatology
- Location Santee, CA
- Active Since 04/02/2018
- Last Updated 10/19/2022
- Taxonomy Code 207ND0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548766264
Products in Payments
- OPZELURA (Drug) $285.74
- TREMFYA (Drug) $280.03
- Sotyktu (Drug) $226.51
- DUPIXENT (Biological) $221.98
- VTAMA (Drug) $213.46
- SKYRIZI (Biological) $150.26
- Otezla (Drug) $96.33
- RINVOQ (Biological) $75.45
- ADBRY (Biological) $74.59
- Zoryve (Drug) $62.92
- EUCRISA (Drug) $56.29
- TALTZ (Drug) $50.88
- Bimzelx (Biological) $45.45
- HUMIRA (Biological) $24.02
- ILUMYA (Biological) $23.15
- AKLIEF (Drug) $21.06
- COSENTYX (Biological) $20.40
- Seysara (Drug) $19.51
- CIBINQO (Drug) $18.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.